Amrize (AMRZ) director buys 2,000 shares at $47.34 in Form 4
Amrize Ltd (AMRZ) director share purchase disclosed.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Amrize Ltd (AMRZ) director share purchase disclosed. A reporting person serving as a director of Amrize Ltd bought 2,000 ordinary shares on 11/19/2025 at a price of $47.34 per share in an open-market purchase coded "P." After this transaction, the director beneficially owns 4,958 ordinary shares held directly. The filing does not report any transactions in derivative securities.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Ordinary Shares | 2,000 | $47.34 | $95K |
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Amrize Ltd (AMRZ) report in this Form 4?
What is the insider’s relationship to Amrize Ltd (AMRZ)?
Were any derivative securities reported in this Amrize Ltd (AMRZ) Form 4?
Is the Amrize Ltd (AMRZ) Form 4 filed for one or multiple reporting persons?
AI-generated analysis. How Rhea-AI works. Not financial advice.